A new platelet cryoprecipitate glue promoting bone formation after ectopic mesenchymal stromal cell-loaded biomaterial implantation in nude mice

Stem Cell Research and Therapy

Volumn 4, Issue 1, 2013, Pages

  Trouillas, Marina ^a   Prat, Marie ^a   Doucet, Christelle ^b   Ernou, Isabelle ^a   Laplace Builhé, Corinne ^c   Blancard, Patrick Saint ^d   Holy, Xavier ^e   Lataillade, Jean Jacques ^a,f  

^a Centre de Transfusion Sanguine des Armees Jean Julliard   (France)

^b CELOGOS   (France)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d PERCY MILITARY HOSPITAL   (France)

^e INSTITUT DE RECHERCHE BIOMÉDICALE DES ARMÉES   (France)

^f Hôpital Inter Armées du Val de Grâce   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGIC GLUE; BIOMATERIAL; CALCIUM PHOSPHATE; COLLAGEN TYPE 1; CYTOKINE; GROWTH FACTOR; HYDROXYAPATITE; MESSENGER RNA; OSTEONECTIN; OSTEOPONTIN; PLATELET GLUE OBTAINED FROM CRYOPRECIPITATION OF APHERESIS PLATELET PRODUCTS; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG; ADHESIVE AGENT; BIOLOGICAL MARKER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE IMPLANT; BONE REMODELING; CELL GROWTH; CELL PROLIFERATION; CERAMIC PROSTHESIS; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CRYOPRECIPITATE; CULTURE MEDIUM; ECTOPIC TISSUE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STROMA CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; NUDE MOUSE; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTOPHERESIS; UPREGULATION; ANIMAL; BONE; CELL DIFFERENTIATION; CELL LINE; DRUG EFFECTS; METABOLISM; PROCEDURES; THROMBOCYTE; TISSUE ENGINEERING;

ADHESIVES; ANIMALS; BIOCOMPATIBLE MATERIALS; BIOLOGICAL MARKERS; BLOOD PLATELETS; BONE AND BONES; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; HUMANS; MESENCHYMAL STROMAL CELLS; MICE; MICE, NUDE; OSTEOBLASTS; OSTEOGENESIS; RNA, MESSENGER; TISSUE ENGINEERING;

EID: 84873638509     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt149     Document Type: Article

References (68)

1. A tissue engineering approach to bone repair in large animal models and in clinical practice. Cancedda R, Giannoni P, Mastrogiacomo M, Biomaterials 2007 28 4240 4250 10.1016/j.biomaterials.2007.06.023 17644173
2. Biology of cancellous bone grafts. Heiple KG, Goldberg VM, Powell AE, Bos GD, Zika JM, Orthop Clin North Am 1987 18 179 185 3550570
3. Tissue engineering for bone defect healing: an update on a multi-component approach. Drosse I, Volkmer E, Capanna R, De Biase P, Mutschler W, Schieker M, Injury 2008 39 Suppl 2 9 20 18804579
4. Biomaterials for stem cell differentiation. Dawson E, Mapili G, Erickson K, Taqvi S, Roy K, Adv Drug Deliv Rev 2008 60 215 228 10.1016/j.addr.2007.08.037 17997187
5. Current views on calcium phosphate osteogenicity and the translation into effective bone regeneration strategies. Chai YC, Carlier A, Bolander J, Roberts SJ, Geris L, Schrooten J, Van Oosterwyck H, Luyten FP, Acta Biomater 2012 8 3876 3887 10.1016/j.actbio.2012.07.002 22796326
6. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini FC, Deans RJ, Krause DS, Keating A, Cytotherapy 2005 7 393 395 10.1080/14653240500319234 16236628
7. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Friedenstein AJ, Gorskaja JF, Kulagina NN, Exp Hematol 1976 4 267 274 976387
8. Multilineage potential of adult human mesenchymal stem cells. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR, Science 1999 284 143 147 10.1126/science.284.5411.143 10102814
9. Immunoregulatory function of mesenchymal stem cells. Uccelli A, Moretta L, Pistoia V, Eur J Immunol 2006 36 2566 2573 10.1002/eji.200636416 17013987
10. The role of mesenchymal stem cells in maintenance and repair of bone. Bielby R, Jones E, McGonagle D, Injury 2007 38 Suppl 1 26 32 17383482
11. Autologous bone marrow stromal cells loaded onto porous hydroxyapatite ceramic accelerate bone repair in critical-size defects of sheep long bones. Kon E, Muraglia A, Corsi A, Bianco P, Marcacci M, Martin I, Boyde A, Ruspantini I, Chistolini P, Rocca M, Giardino R, Cancedda R, Quarto R, J Biomed Mater Res 2000 49 328 337 10.1002/(SICI)1097-4636(20000305)49:3<328::AID-JBM5>3.0.CO;2-Q 10602065
12. Long-bone critical-size defects treated with tissue-engineered grafts: a study on sheep. Viateau V, Guillemin G, Bousson V, Oudina K, Hannouche D, Sedel L, Logeart-Avramoglou D, Petite H, J Orthop Res 2007 25 741 749 10.1002/jor.20352 17318898
13. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Horwitz EM, Prockop DJ, Fitzpatrick LA, Koo WW, Gordon PL, Neel M, Sussman M, Orchard P, Marx JC, Pyeritz RE, Brenner MK, Nat Med 1999 5 309 313 10.1038/6529 10086387
14. Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta. Le Blanc K, Gotherstrom C, Ringden O, Hassan M, McMahon R, Horwitz E, Anneren G, Axelsson O, Nunn J, Ewald U, Nordén-Lindeberg S, Jansson M, Dalton A, Aström E, Westgren M, Transplantation 2005 79 1607 1614 10.1097/01.TP.0000159029.48678.93 15940052
15. Repair of large bone defects with the use of autologous bone marrow stromal cells. Quarto R, Mastrogiacomo M, Cancedda R, Kutepov SM, Mukhachev V, Lavroukov A, Kon E, Marcacci M, N Engl J Med 2001 344 385 386 10.1056/NEJM200102013440516 11195802
16. Stem cells associated with macroporous bioceramics for long bone repair: 6- to 7-year outcome of a pilot clinical study. Marcacci M, Kon E, Moukhachev V, Lavroukov A, Kutepov S, Quarto R, Mastrogiacomo M, Cancedda R, Tissue Eng 2007 13 947 955 10.1089/ten.2006.0271 17484701
17. Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications. Doucet C, Ernou I, Zhang Y, Llense JR, Begot L, Holy X, Lataillade JJ, J Cell Physiol 2005 205 228 236 10.1002/jcp.20391 15887229
18. Fibroblastic response to treatment with different preparations rich in growth factors. Anitua E, Sanchez M, Zalduendo MM, de la Fuente M, Prado R, Orive G, Andia I, Cell Prolif 2009 42 162 170 10.1111/j.1365-2184.2009.00583.x 19250293
19. Growth factor-rich plasma increases tendon cell proliferation and matrix synthesis on a synthetic scaffold: an in vitro study. Visser LC, Arnoczky SP, Caballero O, Kern A, Ratcliffe A, Gardner KL, Tissue Eng Part A 2010 16 1021 1029 10.1089/ten.tea.2009.0254 19839921
20. Platelet-rich plasma: Growth factor enhancement for bone grafts. Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR, Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998 85 638 646 10.1016/S1079-2104(98) 90029-4 9638695
21. Platelets and wound healing. Nurden AT, Nurden P, Sanchez M, Andia I, Anitua E, Front Biosci 2008 13 3532 3548 18508453
22. The use of platelet-rich plasma in bone reconstruction therapy. Intini G, Biomaterials 2009 30 4956 4966 10.1016/j.biomaterials.2009.05.055 19573909
23. Combination of platelet-rich plasma with polycaprolactone-tricalcium phosphate scaffolds for segmental bone defect repair. Rai B, Oest ME, Dupont KM, Ho KH, Teoh SH, Guldberg RE, J Biomed Mater Res A 2007 81 888 899 17236215
24. Platelet-rich plasma inhibits demineralized bone matrix-induced bone formation in nude mice. Ranly DM, Lohmann CH, Andreacchio D, Boyan BD, Schwartz Z, J Bone Joint Surg Am 2007 89 139 147 10.2106/JBJS.F.00388 17200321
25. Platelet-rich plasma diminishes calvarial bone repair associated with alterations in collagen matrix composition and elevated CD34+ cell prevalence. Giovanini AF, Deliberador TM, Gonzaga CC, de Oliveira Filho MA, Gohringer I, Kuczera J, Zielak JC, de Andrade Urban C, Bone 2010 46 1597 1603 10.1016/j.bone.2010.02.026 20206725
26. Combined use of platelet-rich plasma and autologous bone grafts in the treatment of long bone defects in mini-pigs. Hakimi M, Jungbluth P, Sager M, Betsch M, Herten M, Becker J, Windolf J, Wild M, Injury 2010 41 811 817
27. Transplantation of culture expanded bone marrow cells and platelet rich plasma in distraction osteogenesis of the long bones. Kitoh H, Kitakoji T, Tsuchiya H, Katoh M, Ishiguro N, Bone 2007 40 522 528 10.1016/j.bone.2006.09.019 17070744
28. Mesenchymal stem cells and platelet-rich plasma enhance bone formation in sinus grafting: a histomorphometric study in minipigs. Pieri F, Lucarelli E, Corinaldesi G, Iezzi G, Piattelli A, Giardino R, Bassi M, Donati D, Marchetti C, J Clin Periodontol 2008 35 539 546 10.1111/j.1600-051X.2008.01220.x 18422697
29. Mechanisms of ectopic bone formation by human osteoprogenitor cells on CaP biomaterial carriers. Chai YC, Roberts SJ, Desmet E, Kerckhofs G, van Gastel N, Geris L, Carmeliet G, Schrooten J, Luyten FP, Biomaterials 2012 33 3127 3142 10.1016/j.biomaterials.2012.01.015 22269651
30. Osteoblastic differentiation of human mesenchymal stem cells with platelet lysate. Chevallier N, Anagnostou F, Zilber S, Bodivit G, Maurin S, Barrault A, Bierling P, Hernigou P, Layrolle P, Rouard H, Biomaterials 2010 31 270 278 10.1016/j.biomaterials.2009.09.043 19783038
31. The role of bFGF on the ability of MSC to activate endogenous regenerative mechanisms in an ectopic bone formation model. Tasso R, Gaetani M, Molino E, Cattaneo A, Monticone M, Bachi A, Cancedda R, Biomaterials 2012 33 2086 2096 10.1016/j.biomaterials.2011.11.043 22169138
32. Pre-culture period of mesenchymal stem cells in osteogenic media influences their in vivo bone forming potential. Castano-Izquierdo H, Alvarez-Barreto J, van den Dolder J, Jansen JA, Mikos AG, Sikavitsas VI, J Biomed Mater Res A 2007 82 129 138 17269144
33. Brief review of models of ectopic bone formation. Scott MA, Levi B, Askarinam A, Nguyen A, Rackohn T, Ting K, Soo C, James AW, Stem Cells Dev 2012 21 655 667 10.1089/scd.2011.0517 22085228
34. Human plasma as a dermal scaffold for the generation of a completely autologous bioengineered skin. Llames SG, Del Rio M, Larcher F, Garcia E, Garcia M, Escamez MJ, Jorcano JL, Holguin P, Meana A, Transplantation 2004 77 350 355 10.1097/01.TP.0000112381.80964.85 14966407
35. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F, Genome Biol 2002 3 RESEARCH0034
36. Cartilage-like gene expression in differentiated human stem cell spheroids: a comparison of bone marrow-derived and adipose tissue-derived stromal cells. Winter A, Breit S, Parsch D, Benz K, Steck E, Hauner H, Weber RM, Ewerbeck V, Richter W, Arthritis Rheum 2003 48 418 429 10.1002/art.10767 12571852
37. The use of plasma-rich growth factors (PRGF) in oral surgery. Anitua E, Pract Proced Aesthet Dent 2001 13 487 493 quiz 487-493 11544821
38. Autologous concentrated platelet-rich plasma (cPRP) for local application in bone regeneration. Dugrillon A, Eichler H, Kern S, Kluter H, Int J Oral Maxillofac Surg 2002 31 615 619 10.1054/ijom.2002.0322 12521317
39. Autologous fibrin glue with growth factors in reconstructive maxillofacial surgery. Thorn JJ, Sorensen H, Weis-Fogh U, Andersen M, Int J Oral Maxillofac Surg 2004 33 95 100 10.1054/ijom.2003.0461 14690664
40. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part I: technological concepts and evolution. Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, Gogly B, Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006 101 37 44 10.1016/j.tripleo.2005.07.008 16504849
41. Cryoprecipitate: the current state of knowledge. Callum JL, Karkouti K, Lin Y, Transfus Med Rev 2009 23 177 188 10.1016/j.tmrv.2009.03.001 19539873
42. Contact activation of blood-plasma coagulation. Vogler EA, Siedlecki CA, Biomaterials 2009 30 1857 1869 10.1016/j.biomaterials.2008.12.041 19168215
43. Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. Bieback K, Hecker A, Kocaomer A, Lannert H, Schallmoser K, Strunk D, Kluter H, Stem Cells 2009 27 2331 2341 10.1002/stem.139 19544413
44. Effect of platelet concentration in platelet-rich plasma on peri-implant bone regeneration. Weibrich G, Hansen T, Kleis W, Buch R, Hitzler WE, Bone 2004 34 665 671 10.1016/j.bone.2003.12.010 15050897
45. Platelets in inflammation and atherogenesis. Gawaz M, Langer H, May AE, J Clin Invest 2005 115 3378 3384 10.1172/JCI27196 16322783
46. Mechanism of divergent growth factor effects in mesenchymal stem cell differentiation. Kratchmarova I, Blagoev B, Haack-Sorensen M, Kassem M, Mann M, Science 2005 308 1472 1477 10.1126/science.1107627 15933201
47. Platelet-released supernatants increase migration and proliferation, and decrease osteogenic differentiation of bone marrow-derived mesenchymal progenitor cells under in vitro conditions. Gruber R, Karreth F, Kandler B, Fuerst G, Rot A, Fischer MB, Watzek G, Platelets 2004 15 29 35 10.1080/09537100310001643999 14985174
48. PDGF, TGF-beta, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages. Ng F, Boucher S, Koh S, Sastry KS, Chase L, Lakshmipathy U, Choong C, Yang Z, Vemuri MC, Rao MS, Tanavde V, Blood 2008 112 295 307 10.1182/blood-2007-07-103697 18332228
49. The role of vascular endothelial growth factor in wound healing. Bao P, Kodra A, Tomic-Canic M, Golinko MS, Ehrlich HP, Brem H, J Surg Res 2009 153 347 358 10.1016/j.jss.2008.04.023 19027922
50. Fracture vascularity and bone healing: a systematic review of the role of VEGF. Keramaris NC, Calori GM, Nikolaou VS, Schemitsch EH, Giannoudis PV, Injury 2008 39 Suppl 2 45 57 18804573
51. Platelets secrete stromal cell-derived factor 1alpha and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo. Massberg S, Konrad I, Schurzinger K, Lorenz M, Schneider S, Zohlnhoefer D, Hoppe K, Schiemann M, Kennerknecht E, Sauer S, Schulz C, Kerstan S, Rudelius M, Seidl S, Sorge F, Langer H, Peluso M, Goyal P, Vestweber D, Emambokus NR, Busch DH, Frampton J, Gawaz M, J Exp Med 2006 203 1221 1233 10.1084/jem.20051772 16618794
52. Influence of biphasic calcium phosphate granulometry on bone ingrowth, ceramic resorption, and inflammatory reactions: preliminary in vitro and in vivo study. Malard O, Bouler JM, Guicheux J, Heymann D, Pilet P, Coquard C, Daculsi G, J Biomed Mater Res 1999 46 103 111 10.1002/(SICI)1097-4636(199907)46: 1<103::AID-JBM12>3.0.CO;2-Z 10357141
53. The in vivo assessment of a novel scaffold containing heparan sulfate for tissue engineering with human mesenchymal stem cells. Luong-Van E, Grondahl L, Song S, Nurcombe V, Cool S, J Mol Histol 2007 38 459 468 10.1007/s10735-007- 9129-y 17694276
54. 3D microenvironment as essential element for osteoinduction by biomaterials. Habibovic P, Yuan H, van der Valk CM, Meijer G, van Blitterswijk CA, de Groot K, Biomaterials 2005 26 3565 3575 10.1016/j.biomaterials.2004.09. 056 15621247
55. Osteoinductive ceramics as a synthetic alternative to autologous bone grafting. Yuan H, Fernandes H, Habibovic P, de Boer J, Barradas AM, de Ruiter A, Walsh WR, van Blitterswijk CA, de Bruijn JD, Proc Natl Acad Sci USA 2010 107 13614 13619 10.1073/pnas.1003600107 20643969
56. Influence of beta-tricalcium phosphate granule size and morphology on tissue reaction in vivo. Ghanaati S, Barbeck M, Orth C, Willershausen I, Thimm BW, Hoffmann C, Rasic A, Sader RA, Unger RE, Peters F, Kirkpatrick CJ, Acta Biomater 2010 6 4476 4487 10.1016/j.actbio.2010.07.006 20624495
57. The chemical composition of synthetic bone substitutes influences tissue reactions in vivo: histological and histomorphometrical analysis of the cellular inflammatory response to hydroxyapatite, beta-tricalcium phosphate and biphasic calcium phosphate ceramics. Ghanaati S, Barbeck M, Detsch R, Deisinger U, Hilbig U, Rausch V, Sader R, Unger RE, Ziegler G, Kirkpatrick CJ, Biomed Mater 2012 7 015005 10.1088/1748-6041/7/1/015005 22287541
58. BMP-silk composite matrices heal critically sized femoral defects. Kirker-Head C, Karageorgiou V, Hofmann S, Fajardo R, Betz O, Merkle HP, Hilbe M, von Rechenberg B, McCool J, Abrahamsen L, Nazarian A, Cory E, Curtis M, Kaplan D, Meinel L, Bone 2007 41 247 255 10.1016/j.bone.2007.04.186 17553763
59. Bone regeneration by implantation of adipose-derived stromal cells expressing BMP-2. Li H, Dai K, Tang T, Zhang X, Yan M, Lou J, Biochem Biophys Res Commun 2007 356 836 842 10.1016/j.bbrc.2007.02.165 17391646
60. In vivo osteogenic potential of human adipose-derived stem cells/poly lactide-co-glycolic acid constructs for bone regeneration in a rat critical-sized calvarial defect model. Yoon E, Dhar S, Chun DE, Gharibjanian NA, Evans GR, Tissue Eng 2007 13 619 627 10.1089/ten.2006.0102 17518608
61. In vitro dexamethasone pretreatment enhances bone formation of human mesenchymal stem cells in vivo. Song IH, Caplan AI, Dennis JE, J Orthop Res 2009 27 916 921 10.1002/jor.20838 19137580
62. The development of tissue-engineered bone of different origin through endochondral and intramembranous ossification following the implantation of mesenchymal stem cells and osteoblasts in a murine model. Tortelli F, Tasso R, Loiacono F, Cancedda R, Biomaterials 2010 31 242 249 10.1016/j.biomaterials. 2009.09.038 19796807
63. The recruitment of two consecutive and different waves of host stem/progenitor cells during the development of tissue-engineered bone in a murine model. Tasso R, Fais F, Reverberi D, Tortelli F, Cancedda R, Biomaterials 2010 31 2121 2129 10.1016/j.biomaterials.2009.11.064 20004968
64. Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells. Kortesidis A, Zannettino A, Isenmann S, Shi S, Lapidot T, Gronthos S, Blood 2005 105 3793 3801 10.1182/blood-2004-11- 4349 15677562
65. Circulating bone marrow-derived osteoblast progenitor cells are recruited to the bone-forming site by the CXCR4/stromal cell-derived factor-1 pathway. Otsuru S, Tamai K, Yamazaki T, Yoshikawa H, Kaneda Y, Stem Cells 2008 26 223 234 10.1634/stemcells.2007-0515 17932420
66. Human adipose-derived stromal cells stimulate autogenous skeletal repair via paracrine hedgehog signaling with calvarial osteoblasts. Levi B, James AW, Nelson ER, Li S, Peng M, Commons GW, Lee M, Wu B, Longaker MT, Stem Cells Dev 2011 20 243 257 10.1089/scd.2010.0250 20698749
67. Paracrine effect of canine allogenic umbilical cord blood-derived mesenchymal stromal cells mixed with beta-tricalcium phosphate on bone regeneration in ectopic implantations. Byeon YE, Ryu HH, Park SS, Koyama Y, Kikuchi M, Kim WH, Kang KS, Kweon OK, Cytotherapy 2010 12 626 636 10.3109/14653249.2010.481665 20438297
68. Influence of platelet-rich plasma on osteogenic differentiation of mesenchymal stem cells and ectopic bone formation in calcium phosphate ceramics. Kasten P, Vogel J, Luginbuhl R, Niemeyer P, Weiss S, Schneider S, Kramer M, Leo A, Richter W, Cells Tissues Organs 2006 183 68 79 10.1159/000095511 17053323